High-purity recombinant Klotho protein and targeted peptide fragments represent crucial reagents for investigating cellular senescence, mineral homeostasis, and FGF23 signal transduction pathways. PX1 Research synthesizes and purifies research-grade Klotho domestically within state-of-the-art, GMP-compliant facilities in the United States. Every production lot undergoes rigorous analytical characterization—including high-performance liquid chromatography (HPLC) and mass spectrometry (MS)—at independent ISO 17025 accredited laboratories to ensure uncompromised quality for preclinical experimentation.
High-purity recombinant Klotho protein and targeted peptide fragments represent crucial reagents for investigating cellular senescence, mineral homeostasis, and FGF23 signal transduction pathways. PX1 Research synthesizes and purifies research-grade Klotho domestically within state-of-the-art, GMP-compliant facilities in the United States. Every production lot undergoes rigorous analytical characterization—including high-performance liquid chromatography (HPLC) and mass spectrometry (MS)—at independent ISO 17025 accredited laboratories to ensure uncompromised quality for preclinical experimentation.
In contemporary bioscientific inquiry, the reproducibility of experimental data depends fundamentally on the structural integrity and purity of reference proteins and peptides. When sourcing research compounds, academic and institutional laboratories increasingly prioritize domestic production to eliminate supply chain volatility and ensure strict adherence to quality control protocols. Sourcing Klotho made in USA through PX1 Research guarantees that every lot is synthesized under stringent quality management systems, bypassing the degradation risks and batch-to-batch inconsistencies frequently associated with unverified overseas distributors.
Domestic manufacturing facilitates transparent documentation and full lot-to-lot traceability. Recombinant proteins and complex peptides are highly susceptible to conformational changes, oxidation, and aggregation if improper synthesis or lyophilization techniques are employed. By maintaining full operational control within domestic facilities located in California and Arizona, PX1 Research applies validated purification protocols designed to yield high-purity, fully bio-active research peptides tailored specifically for advanced in vitro assays and animal model systems.
First identified in rodent genetics literature as an anti-aging gene, the Klotho family comprises three primary isoforms: alpha-Klotho, beta-Klotho, and gamma-Klotho. Alpha-Klotho exists primarily in two distinct molecular forms: a single-pass transmembrane protein and a soluble circulating variant generated via alternative splicing or proteolytic cleavage of the extracellular domain by membrane-bound metalloproteinases (ADAM10 and ADAM17). The transmembrane isoform functions as an essential obligate co-receptor for fibroblast growth factor 23 (FGF23), establishing a high-affinity binding complex with fibroblast growth factor receptors (FGFRs) to regulate systemic phosphate and vitamin D homeostasis.
Conversely, soluble Klotho acts as a circulating endocrine factor capable of modulating diverse intracellular signal transduction cascades independently of FGF23. Preclinical investigations demonstrate that soluble Klotho inhibits the insulin and insulin-like growth factor 1 (IGF-1) signaling pathways, downregulates transforming growth factor-beta 1 (TGF-beta1) activity, and attenuates canonical Wnt signaling. Furthermore, Klotho directly modulates ion channel kinetics, including the TRPC5 and TRPV5 calcium channels, by altering their N-glycan arborization via its intrinsic enzymatic glucuronidase activity. Detailed structural insights can be accessed through our comprehensive research library hub.
In vitro cellular models and genetically engineered rodent lines have established Klotho as a central target in longevity and geroscience research. Genetically targeted mice lacking functional Klotho (kl/kl mutant mice) exhibit an accelerated phenotype resembling human premature aging, characterized by vascular calcification, osteopenia, cognitive impairment, and severe hyperphosphatemia. In contrast, transgenic overexpression models display extended lifespans, reduced oxidative stress markers, and preserved endothelial function.
In cell culture assays, recombinant Klotho administration has been observed to mitigate the senescence-associated secretory phenotype (SASP) in primary human diploid fibroblasts and endothelial cells exposed to genotoxic stress. Research protocols investigating oxidative stress mechanisms demonstrate that Klotho activates the FOXO family of transcription factors—specifically FOXO1 and FOXO3a—thereby upregulating manganese superoxide dismutase (MnSOD) and catalase expression. Researchers evaluating pathways involving cellular renewal often cross-reference these findings with studies examining epitalon, a synthetic tetrapeptide widely investigated for its effects on telomerase expression and cellular replication cycles.
The renal tubular epithelium, particularly within the distal convoluted tubule, serves as the primary site of transmembrane Klotho expression. In this tissue compartment, Klotho coordinates with FGFR1c to bind circulating FGF23 secreted by osteocytes. This signal transduction event initiates a phosphorylation cascade down the MAPK/ERK pathway, resulting in the downregulation of sodium-coupled phosphate cotransporters (NaPi-2a and NaPi-2c) on the apical membrane of proximal renal tubule cells. Consequently, urinary phosphate excretion is enhanced, protecting the organism against hyperphosphatemic calcification.
Additionally, Klotho expression suppresses 1-alpha-hydroxylase enzymatic activity, reducing the systemic synthesis of active 1,25-dihydroxyvitamin D3. In rodent models of chronic kidney disease (CKD), renal expression of Klotho is markedly diminished, correlating directly with interstitial fibrosis and vascular medial calcification. Experimental re-introduction of recombinant Klotho protein in murine models of acute kidney injury (AKI) has demonstrated marked attenuation of tubular apoptosis, inflammatory cytokine production, and fibrogenic gene expression, making it a critical reagent for nephrology research groups.
For biochemical data to meet peer-review publication standards, research reagents must adhere to unambiguous analytical metrics. PX1 Research enforces a zero-compromise quality assurance protocol for all research peptides and recombinant constructs synthesized in the USA. Every production batch is submitted to an independent, third-party ISO 17025 accredited analytical laboratory for characterization prior to distribution.
Analytical validation begins with reverse-phase High-Performance Liquid Chromatography (RP-HPLC) to establish chemical purity, ensuring that target peptide sequences meet or exceed a strictly defined purity threshold (typically >98%). Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) or Electrospray Ionization Mass Spectrometry (ESI-MS) is simultaneously performed to verify exact molecular mass and sequence fidelity. Because cell culture systems and animal models are acutely sensitive to bacterial lipopolysaccharide contamination, every lot undergoes chromogenic Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels remain rigorously controlled below <0.1 EU/mg. Every product shipment includes a batch-specific Certificate of Analysis (COA) documenting these analytical parameters.
When designing multi-target preclinical protocols evaluating cellular resilience, metabolic regulation, and senolytic pathways, researchers frequently compare Klotho to other established peptide compounds within the geroscience portfolio. While Klotho functions as a complex co-receptor modulator and endocrine factor governing phosphate dynamics and IGF-1 cross-talk, short synthetic peptides operate through distinct molecular mechanisms to influence cellular longevity.
For example, researchers studying mitochondrial bioenergetics often pair Klotho assays with ss-31, a cardiolipin-targeting tetrapeptide designed to optimize electron transport chain efficiency and reduce inner-mitochondrial reactive oxygen species (ROS) production. Similarly, in protocols focusing targeted senolysis—the selective clearance of senescent cell populations—investigators utilize foxo4-dri to disrupt p53-FOXO4 binding interactions. Integrating these distinct mechanistic probes within controlled in vitro models allows laboratory investigators to delineate upstream signal inhibition from direct organelle repair and senolytic clearance mechanisms across diverse cell lineages. Additional comparative data can be explored within our longevity research section.
Proper handling and storage techniques are vital to preserve the tertiary structure and biological activity of lyophilized protein and peptide compounds. Research-grade Klotho is supplied as a sterile, lyophilized cake or powder under argon gas to prevent atmospheric oxidation during storage.
For optimal stability, unopened vials should be stored in a freezer maintained at -20°C to -80°C. Prior to reconstitution, vials must be brought to room temperature in a desiccator to prevent moisture condensation on the lyophilized pellet. Reconstitution should be performed using sterile, deionized laboratory-grade water or phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the downstream in vitro or in vivo model. Gentle swirling or inversion is recommended; vigorous vortexing must be avoided, as shear forces can induce peptide denaturation or aggregation. Once reconstituted, stock solutions should be aliquoted into single-use polypropylene microtubes and stored at -80°C to eliminate damage caused by repeated freeze-thaw cycles.
PX1 Research serves as a trusted domestic supply partner for academic universities, government facilities, and private biotechnology laboratories across North America. Sourcing Klotho made in USA ensures compliance with institutional procurement standards, transparent chain of custody, and rapid order fulfillment. All orders placed Monday through Friday before cut-off times are dispatched same-day from centralized fulfillment centers in California and Arizona.
To support large-scale research projects, target screening initiatives, or ongoing longitudinal animal studies, PX1 Research offers flexible volume options and dedicated account management. Laboratories requiring specialized synthesis, custom peptide sequences, or bulk material allocations can request custom quotes through our dedicated wholesale laboratory portal. Our scientific support team provides comprehensive technical documentation, batch-specific COAs, and direct access to analytical data to support your laboratory's experimental rigor.
Where is PX1 Research Klotho synthesized and processed?
PX1 Research Klotho is synthesized, purified, and packaged entirely within state-of-the-art, GMP-compliant facilities located in the United States.
How is the purity of Klotho verified by PX1 Research?
Every production lot undergoes independent, third-party testing at an ISO 17025 accredited laboratory. Purity is validated using High-Performance Liquid Chromatography (HPLC) and identity is confirmed via Mass Spectrometry (MS).
What endotoxin controls are applied to research Klotho?
Each batch is subjected to chromogenic Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain below strictly controlled laboratory thresholds (<0.1 EU/mg), making it suitable for sensitive cell culture and animal models.
How should lyophilized Klotho be stored upon receipt?
Unopened, lyophilized vials should be stored at -20°C to -80°C in a dry environment. To maintain long-term stability, keep the compound protected from light and moisture.
What solvent is recommended for reconstituting Klotho for in vitro assays?
Reconstitution protocols typically utilize sterile laboratory-grade water, phosphate-buffered saline (PBS, pH 7.4), or an appropriate sterile assay buffer. Reconstituted stock solutions should be aliquoted and frozen to avoid repeated freeze-thaw cycles.
Can PX1 Research provide batch-specific Certificate of Analysis (COA) documentation?
Yes. A batch-specific COA detailing HPLC chromatograms, mass spectrum analysis, and endotoxin assay results is included with every shipment and available upon request for institutional verification.
What are the primary receptor pathways studied in Klotho research?
Preclinical studies primarily focus on Klotho as an obligate co-receptor for FGF23 via FGFR complexes, as well as its soluble interactions with the IGF-1, Wnt, and TGF-beta signaling pathways.
Does PX1 Research support bulk or institutional wholesale accounts?
Yes. Institutional researchers and high-volume laboratories can establish accounts via our wholesale portal to secure bulk pricing, reserved lot allocations, and custom batch testing.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.